This approach is not, "Urinary Neurotransmitter Testing". This approach is better and unlike the urinary neurotransmitter testing model it is backed up by peer-reviewed scientific literature.

Laboratory research and testing of DBS Labs is the basis for peer reviewed literature published by medical schools.

 

 
What We Are
The "organic cation transporter functional status analysis" (OCT assay interpretation) performed by doctors on the laboratory monoamine testing of DBS Labs is a patent pending approach covered in peer-reviewed scientific literature. OCT assay interpretation utilizes urinary serotonin and urinary dopamine assays to determine OCT transporter functional status.

Neurotransmitter levels found on testing are not a function of amino acid dosing

Neurotransmitter levels found in the central nervous system, peripheral system and urine are not a function of amino acid dosing they are a function of transporter status. Interpretation under the urinary neurotransmitter testing model to find if neurotransmitter levels are high or low is meaningless and of no value.
 
An In-depth Peer-reviewed Article
on Urinary Neurotransmitter Testing
Authors: Marty Hinz, MD Alvin Stein, MD George Trachte, PhD Thomas Uncini, MD
Approved for Publication July 27, 2010
Comprehensive Analysis of Urinary Neurotransmitter Testing
Simply interpreting urinary neurotransmitter testing as "high or low" without determination of the transporter status is meaningless and not valid according to peer-reviewed literature, although there is a significant group of people who erroneously believe the urinary neurotransmitter testing model is valid. The OCT assay interpretation approach moves determination of neurotransmitter and transporter status into the realm of legitimate science from the world of the intuitive where urinary neurotransmitter testing is obtained because it sounds good with no science backing up validity. We encourage you to read this paper which discusses what is and is not valid in the world of the urinary neurotransmitter testing model.
 
The University of Minnesota Medical School
Authors: George Trachte, PhD Thomas Uncini, MD Marty Hinz, MD
Peer Reviewed Literature Released May 2, 2009
University of Minnesota Medical School Paper

This paper is the first paper of a series of papers written by the University of Minnesota based on the findings of this research project. The paper outlines the "3 phase response" of urinary serotonin and urinary dopamine which is the basis for the OCT assay interpretation model.

 
Johns Hopkins Medical School Text Book
Authors Marty Hinz, MD
Peer Reviewed Literature Released February 7, 2009
Johns Hopkins Chapter 29-Depression

Chapter 29, "Depression" from "Food and Nutrients in Disease Management" Ingrid Kohlstadt, MD Editor-Johns Hopkins Medical School. This is the first peer reviewed literature to discuss the "3 phase response" of urinary serotonin and urinary dopamine to administration of serotonin and dopamine amino acid precursors in varied doses.

 
The Organic Cation Transporter Model
Authors: Marty Hinz, MD Alvin Stein, MD Thomas Uncini, MD
Peer Reviewed Literature Published July 2, 2010
OCT Assays

  This article is an in-depth explanation of how amino acids transporters, and neurotransmitter interact leading to the neurotransmitter levels found on assay..

 
DBS Labs 8723 Falcon St. Duluth, MN 55808 Phone number: 877-476-7229
Tom Uncini, MD
Neurotransmitter testing
DBS Laboratory Director
 
Dual Board Certified Pathologist
- Laboratory Medicine
- Forensic Pathology
 
Chief of Pathology Hibbing Hospital and Cook Hospital
 
Lab Director Hibbing Hospital
Lab Director Cook Hospital
 
St. Louis County Medical Examiner